0001225208-14-005201.txt : 20140219
0001225208-14-005201.hdr.sgml : 20140219
20140219205138
ACCESSION NUMBER: 0001225208-14-005201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140216
FILED AS OF DATE: 20140219
DATE AS OF CHANGE: 20140219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Onuscheck John Michael
CENTRAL INDEX KEY: 0001440474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 14627631
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
4
1
doc4.xml
X0306
4
2014-02-16
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001440474
Onuscheck John Michael
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
SVP & President, Europe
Common Stock
2014-02-16
4
M
0
5060.0000
0.0000
A
78853.0000
D
Common Stock
2014-02-16
4
F
0
2837.0000
13.3000
D
76016.0000
D
Deferred Stock Units
2014-02-16
4
M
0
5060.0000
0.0000
D
Common Stock
5060.0000
64957.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
Reflects multiple DSU awards with independent vesting schedules.
onuscheckpoa.txt
/s/ Lee G. Giguere, Attorney-in-Fact
2014-02-19
EX-24
2
onuscheckpoa.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and
appoints each of Timothy A. Pratt, Vance R. Brown, Theresa R. Boni, Scott G.
Hodgdon
and Lee G. Giguere signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) prepare and execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a
Form
ID, including amendments thereto, and any other documents necessary or
appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings
with the SEC of reports required by Section 16(a) of the Securities Exchange Act
of
1934, as amended, or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's
capacity as an executive officer and/or director of Boston Scientific
Corporation
(the "Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder;
(3) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4
or 5
and file such form with the SEC and any stock exchange or similar authority;
(4) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or director of the Company, Forms 144 in accordance
with
Rule 144 of the Securities Act of 1933, as amended, and the rules and
regulations
thereunder; and
(5) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in
the best interest of, or legally required by, the undersigned, it being
understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done
by virtue of this power of attorney and the rights and powers herein granted.
The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such
capacity at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the
Securities Exchange Act of 1934, as amended, or Rule 144 of the Securities Act
of
1933, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with
respect to the undersigned's holdings of and transactions in securities issued
by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29th day of January, 2014.
/s/ J. Michael Onuscheck
________________________
J. Michael Onuscheck